Brief Articles
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. May 28, 2009; 15(20): 2520-2525
Published online May 28, 2009. doi: 10.3748/wjg.15.2520
Table 1 Summary of gastric cancer and methylation of CHFR
Case No.Age (yr)SexLauren classificationCHFR methylation
MIN status2P53 mutation
TumorNormal
186MIntestinal+-MSSMutant
267FDiffuse+-MSI-LWild
376FIntestinal++MSSWild
430FDiffuse--MSSWild
574MDiffuse-+ND1Mutant
642MDiffuse++MSSWild
778MDiffuse--MSSWild
855MDiffuse--MSSMutant
950FDiffuse--MSSWild
1055MIntestinal--MSSWild
1163MDiffuse--MSSWild
1269MIntestinal-+MSSMutant
1352MIntestinal--MSSWild
1480MDiffuse+-MSI-HWild
1573FDiffuse--MSSWild
1674MIntestinal--MSSWild
1739FDiffuse--MSSWild
1853FDiffuse+-MSSWild
1959MDiffuse+-MSSMutant
2072MIntestinal+-MSSWild
2169MIntestinal--MSSWild
2251MDiffuse--MSSWild
2361MDiffuse--MSI-LWild
2465MDiffuse--MSI-LWild
2556MDiffuse--MSSWild
2653MDiffuse--MSSWild
2742MDiffuse--MSI-HWild
2859FIntestinal--MSSMutant
2967MIntestinal--MSSMutant
3055FDiffuse--MSSWild
3168MIntestinal+-MSI-LWild
3273MIntestinal--MSSWild
3349FDiffuse+-MSSWild
3452FDiffuse--MSSWild
3569MDiffuse--MSSWild
3673MIntestinal+-MSSWild
3763MDiffuse--MSSWild
3873FIntestinal--MSSWild
3965MIntestinal--MSSWild
4060MDiffuse--MSSMutant
4148FDiffuse--MSSWild
4269FDiffuse+-MSI-LWild
4381FIntestinal+-MSSWild
4460MIntestinal++MSI-LWild
4559MIntestinal+-MSI-HWild
4657MDiffuse+-MSSWild
4766FIntestinal--MSSWild
4868MIntestinal--MSSWild
4956FIntestinal--MSSWild
5064FDiffuse+-MSSWild
5145FDiffuse--MSSWild
5268MDiffuse--MSSWild
5367MDiffuse--MSSWild
5466MDiffuse--NDWild
5555MDiffuse+-MSI-HWild
5652FIntestinal+-MSSWild
5777FIntestinal+-MSSWild
5861MIntestinal-+NDWild
5970FDiffuse--MSSWild
Table 2 Clinicopathological features of gastric cancer and methylation of CHFR
VariableNegative
Methylated
P value
n= 39n= 20
Gender
Male2611NS
Female139
Age60.564.6NS
Histology
Intestinal1410NS
Diffuse2510
Serosal invasion
Negative158NS
Positive2412
Histological lymph node metastasis
Negative155NS
Positive2415
Vascular involvement
Negative2214NS
Positive146
Peritoneal dissemination
Negative3217NS
Positive73
Stage
I + II125NS
III + IV2715
p53 mutation
Wild3318NS
Mutation62
MIN status
MSI-H/L37< 0.01
MSS3613